Compare Axogen Inc (AXGN) vs Dolby Laboratories, Inc. (DLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Dolby Laboratories, Inc. — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while Dolby Laboratories, Inc. trades at $60.91 (market cap $5.75B). The key difference: Dolby Laboratories, Inc. is far larger — about 2.2× Axogen Inc's market cap, and Dolby Laboratories, Inc. pays a 2.35% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | DLB | |
|---|---|---|
Market Cap | $2.61B | $5.75B |
Sector | Technology | Industrials |
52-Week High | $48.48 | $75.62 |
52-Week Low | $14.16 | $48.51 |
Enterprise Value | $2.52B | $5.12B |
Dividend Yield | — | 2.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →
